A detailed history of Corton Capital Inc. transactions in Innoviva, Inc. stock. As of the latest transaction made, Corton Capital Inc. holds 10,286 shares of INVA stock, worth $197,902. This represents 0.1% of its overall portfolio holdings.

Number of Shares
10,286
Previous 13,559 24.14%
Holding current value
$197,902
Previous $222,000 10.81%
% of portfolio
0.1%
Previous 0.12%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$16.33 - $20.04 $53,448 - $65,590
-3,273 Reduced 24.14%
10,286 $198,000
Q2 2024

Aug 14, 2024

BUY
$14.4 - $16.4 $195,249 - $222,367
13,559 New
13,559 $222,000

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.34B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Corton Capital Inc. Portfolio

Follow Corton Capital Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Corton Capital Inc., based on Form 13F filings with the SEC.

News

Stay updated on Corton Capital Inc. with notifications on news.